Semaglutide vs Tirzepatide vs Retatrutide: Side Effects

    •By Trimi Medical Team•14 min read

    All GLP-1 medications share a similar core side effect profile (primarily gastrointestinal), but the severity, duration, and specific effects differ between semaglutide, tirzepatide, and retatrutide. Understanding these differences helps you choose the medication most likely to be tolerable for your body.

    Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Side effects vary significantly between individuals. Report any concerning symptoms to your healthcare provider immediately.

    Side Effect Comparison Table

    Side EffectSemaglutideTirzepatideRetatrutide
    Nausea40-45%35-40%40-50%
    Vomiting15-20%10-15%15-20%
    Diarrhea25-30%15-20%25-30%
    Constipation15-20%15-20%15-20%
    Increased Heart RateMinimalMinimalModerate (glucagon)
    Feeling Warm/HotUncommonUncommonCommon (thermogenesis)
    Hair ThinningRelated to weight loss rateModerate-HighHigher
    Discontinuation Rate~5-7%~3-5%~5-8%

    Key Differences Explained

    Semaglutide: The Most-Studied Profile

    Semaglutide has the most long-term safety data (15+ years for the GLP-1 class). Its side effects are well-characterized and predominantly gastrointestinal. Most side effects improve within 4-8 weeks of each dose increase. Nausea tends to be worst during the first few days after each injection.

    Tirzepatide: Generally Best Tolerated

    Despite producing more weight loss, tirzepatide tends to have slightly lower nausea and vomiting rates than semaglutide in head-to-head comparisons. The GIP component may have a buffering effect on GLP-1-related nausea. Tirzepatide has the lowest discontinuation rate due to side effects among the three medications.

    Retatrutide: Unique Glucagon Effects

    Retatrutide's glucagon receptor activation introduces side effects not seen with semaglutide or tirzepatide. The increased thermogenesis can make patients feel warm or slightly flushed. A modest increase in resting heart rate (3-5 bpm) is common. GI side effects are comparable to semaglutide but with the added complexity of three-receptor activation.

    Managing Side Effects: Universal Strategies

    • Eat slowly and smaller portions: The most effective nausea prevention
    • Stay hydrated: Dehydration worsens every side effect
    • Ginger supplements: Clinically proven for GLP-1-related nausea
    • Titrate gradually: Do not rush dose increases
    • Time injections strategically: Some patients do better injecting in the evening

    Choose Your Best Fit with Trimi

    Trimi's medical team helps match you with the right medication for your tolerability. Compounded semaglutide is $99/month and compounded tirzepatide is $125/month. Visit our treatment page to start.

    Frequently Asked Questions

    Which GLP-1 has the fewest side effects?

    Tirzepatide has the lowest discontinuation rate due to side effects in clinical trials, making it the best-tolerated option overall. However, individual responses vary. Some patients tolerate semaglutide perfectly but struggle with tirzepatide, and vice versa.

    Do side effects get worse with stronger medications?

    Not necessarily. Side effects are primarily dose-dependent (higher doses = more side effects) rather than medication-dependent. Because all three medications start at low doses and titrate up, the side effect experience is similar during the early weeks regardless of which medication you choose.

    Can I switch to avoid specific side effects?

    Yes. If you have persistent side effects on one medication, switching to another GLP-1 may resolve them. The different receptor profiles mean your body may respond differently to each medication.

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Related Reading

    How do the side effects of semaglutide, tirzepatide, and retatrutide compare?

    Semaglutide and tirzepatide are FDA-approved and have well-characterized side-effect profiles dominated by transient gastrointestinal symptoms, nausea, diarrhea, vomiting, constipation. Reported nausea rates are roughly 30–45% for semaglutide, 25–40% for tirzepatide. Retatrutide is investigational (a triple receptor agonist targeting GLP-1, GIP, and glucagon) and not yet FDA-approved; phase-2 data show greater weight loss than tirzepatide but also higher rates of GI side effects, consistent with the broader pharmacological intensity. Side effects in all three diminish at each titration step over 2–4 weeks.

    Side-effect class is the same; rates trend with pharmacological intensity.
    Retatrutide is investigational and not yet FDA-approved.
    Slow titration mitigates GI symptoms across the class.

    Key Takeaways

    • Semaglutide, tirzepatide, and retatrutide share the same dominant side-effect class, gastrointestinal symptoms during dose titration.
    • Retatrutide (a triple agonist on GLP-1, GIP, and glucagon receptors) is investigational; not yet FDA-approved.
    • Side-effect rates trend slightly higher with greater pharmacological intensity, paralleling efficacy.
    • All three follow gradual dose escalation to reduce gastrointestinal effects.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: February 21, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.

    Outcome: Same-day delivery experience

    - Veronica LarimoreFacebook
    It's only been 2 weeks since I've been taking the VialsRx meds from Trimi. The medication showed up pretty quickly (about 4 days after getting approval from Trimi prescriber) and I received 3 vials for my first 3 months on the subscription. For the price and convenience my take is that Trimi and VialsRx is good.

    Outcome: 4-day delivery; 3 vials for first 3 months; price + convenience verdict positive

    - u/CSWB101Reddit (r/TirzepatideRX)
    See all community reviews →

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Novo Nordisk (2025). Wegovy (semaglutide) prescribing information. U.S. Food and Drug Administration.Read Study
    2. Eli Lilly and Company (2025). Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration.Read Study
    3. Frías JP, et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. The New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2107519

    Was this article helpful?

    Keep Reading

    Comparisons

    Semaglutide vs Tirzepatide vs Phentermine vs Metformin for Weight Loss

    Four-way comparison of the most prescribed weight loss medications in 2026. Compare efficacy, side effects, cost, duration of use, and who each drug is best for.

    13 minRead More
    Comparisons

    Calibrate vs Telehealth Tirzepatide

    Calibrate vs Telehealth: side-by-side comparison of pricing, clinician access, pharmacy disclosure, and program structure. Verified 2026 cost data plus how each stacks against Trimi.

    10 minRead More
    Comparisons

    Hims vs Telehealth Tirzepatide

    Hims vs Telehealth: side-by-side comparison of pricing, clinician access, pharmacy disclosure, and program structure. Verified 2026 cost data plus how each stacks against Trimi.

    10 minRead More
    Comparisons

    Fridays vs Trimi for Tirzepatide Access

    Fridays vs Trimi: side-by-side comparison of pricing, clinician access, pharmacy disclosure, and program structure. Verified 2026 cost data plus how each stacks against Trimi.

    10 minRead More

    Start your GLP-1 journey, from $99/mo

    Get Started